Jeremy Grant's most recent trade in Theravance Biopharma Inc was a trade of 24,258 Share Option (Right to Buy) done . Disclosure was reported to the exchange on May 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Theravance Biopharma Inc | Jeremy Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 24,258 | 24,258 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Jeremy Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 10,649 | 32,954 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Jeremy Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 23,576 | 23,576 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Jeremy Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 10,537 | 22,305 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Grant Jeremy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 19,734 | 19,734 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Jeremy Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 8,826 | 8,826 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Grant Jeremy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 6,578 | 6,578 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Grant Jeremy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 2,942 | 11,768 (0%) | 0% | 0 | Ordinary Shares |